-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Integra Lifesciences Holdings Corp quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Integra Lifesciences Holdings Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.15M, a 131% decline year-over-year.
- Integra Lifesciences Holdings Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was $28.8M, a 79.9% decline year-over-year.
- Integra Lifesciences Holdings Corp annual Operating Income (Loss) for 2023 was $112M, a 53.3% decline from 2022.
- Integra Lifesciences Holdings Corp annual Operating Income (Loss) for 2022 was $239M, a 21.1% increase from 2021.
- Integra Lifesciences Holdings Corp annual Operating Income (Loss) for 2021 was $197M, a 30.3% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)